Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance

Journal of Infectious Diseases

Volumn 203, Issue 2, 2011, Pages 168-174

  Ghedin, Elodie ^a,f   Laplante, Jennifer ^c   DePasse, Jay ^a   Wentworth, David E ^c,d   Santos, Roberto P ^e   Lepow, Martha L ^e   Porter, Joanne ^e   Stellrecht, Kathleen ^e   Lin, Xudong ^c   Operario, Darwin ^c   Griesemer, Sara ^c   Fitch, Adam ^a   Halpin, Rebecca A ^f   Stockwell, Timothy B ^f   Spiro, David J ^f   Holmes, Edward C ^b,g   St George, Kirsten ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c WADSWORTH CENTER   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

^e ALBANY MEDICAL CENTER   (United States)

^f J CRAIG VENTER INSTITUTE   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CEFEPIME; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; LEVOFLOXACIN; METHOTREXATE; OSELTAMIVIR; SIALIDASE INHIBITOR; VANCOMYCIN; VINCRISTINE; ZANAMIVIR;

ARTICLE; CLADISTICS; FEVER; GENE MUTATION; GENETIC VARIABILITY; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MALE; MIXED INFECTION; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T CELL LEUKEMIA;

ADOLESCENT; ANTIVIRAL AGENTS; BIODIVERSITY; DRUG RESISTANCE, VIRAL; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MOLECULAR SEQUENCE DATA; OSELTAMIVIR; PANDEMICS; PHYLOGENY; RNA, VIRAL; SEQUENCE HOMOLOGY;

EID: 79851506072     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq040     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:893-6.
2. Englund JA, Champlin RE, Wyde PR, et al. Common emergence of amantadine- rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 1998; 26:1418-24. (Pubitemid 28270175)
3. Gooskens J, Jonges M, Claas EC, Meijer A, Kroes AC. Prolonged influenza virus infection during lymphocytopenia frequent detection of drug-resistant viruses. J Infect Dis 2009; 199:1435-41.
4. Weinstock DM, Gubareva LV, Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 2003; 348:867-8. (Pubitemid 36245772)
5. Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG. Recovery of drug-resistant influenza virus from immunocompromised patients: A case series. J Infect Dis 2006; 193:760-4.
6. Klimov AI, Rocha E, Hayden FG, Shult PA, Roumillat LF, Cox NJ. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: Detection by polymerase chain reaction-restriction analysis. J Infect Dis 1995; 172:1352-5.
7. Ghedin E, Fitch A, Boyne A, et al. Mixed infection the genesis of influenza virus diversity. J Virol 2009; 83:8832-41.
8. Fraser C, Donnelly CA, Cauchemez S, et al. Pandemic potential of a strain of influenza A (H1N1): Early findings. Science 2009; 324:1557-61.
9. Centers for Disease Control and Prevention (CDC). Update: Drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep 2009; 58:433-5.
10. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis-North Carolina, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:969-72.
11. Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med 2009; 361:2296-7.
12. Chen H, Cheung CL, Tai H, et al. Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis 2009; 15:1970-2.
13. Le QM, Wertheim HF, Tran ND, van Doorn HR, Nguyen TH, Horby P. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med 2010; 362:86-7.
14. Moscona A. Oseltamivir resistance-disabling our influenza defenses. N Engl J Med 2005; 353:2633-6. (Pubitemid 41817709)
15. Chan PA, Connell NT, Gabonay AM, et al. Oseltamivir-resistant 2009-2010 pandemic influenza A (H1N1) in an immunocompromised patient. Clin Microbiol Infect 2010. [Epub ahead of print].
16. Harvala H, Gunson R, Simmonds P, et al. The emergence of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. Euro Surveill 2010; 15.
17. Memoli MJ, Hrabal RJ, Hassantoufighi A, Eichelberger MC, Taubenberger JK. Rapid selection of oseltamivir- peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clin Infect Dis 2010; 50:1252-5.
18. Zhou B, Donnelly ME, Scholes DT, et al. Single-reaction genomic amplification accelerates sequencing vaccine production for classical and Swine origin human influenza a viruses. J Virol 2009; 83:10309-13.
19. Djikeng A, Halpin R, Kuzmickas R, et al. Viral genome sequencing by random priming methods. MC Genomics 2008; 9:5.
20. Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005; 437:376-80. (Pubitemid 41613494)
21. Ghedin E, Sengamalay NA, Shumway M, et al. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 2005; 437:1162-6. (Pubitemid 41509354)
22. Kurtz S, Phillippy A, Delcher AL, et al. Versatile open software for comparing large genomes. Genome Biol 2004; 5:R12.
23. Li W, Godzik A. Cd-hit: A fast program for clustering comparing large sets of protein or nucleotide sequences. Bioinformatics 2006; 22: 1658-9. (Pubitemid 43985301)
24. Edgar RC. MUSCLE: Multiple sequence alignment with high accuracy high throughput. Nucleic Acids Res 2004; 32:1792-7. (Pubitemid 38832724)
25. Eddy SR. Profile hidden Markov models. Bioinformatics 1998; 14:755-63. (Pubitemid 28552108)
26. Quinlan AR, Stewart DA, Stromberg MP, Marth GT. Pyrobayes: An improved base caller for SNP discovery in pyrosequences. Nat Methods 2008; 5:179-81. (Pubitemid 351181747)
27. Guindon S, Gascuel O. A simple, fast, accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003; 52:696-704. (Pubitemid 37365050)
28. Zwickl DJ. Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion Ph.D. dissertation. 2006. The University of Texas at Austin.
29. Deyde VM, Sheu TG, Trujillo AA, et al. Detection of molecular markers of drug resistance in the 2009 pandemic influenza A (H1N1) viruses using pyrosequencing. Antimicrob Agents Chemother 2010; 54: 1102-10.
30. Nelson M, Spiro D, Wentworth D, et al. The early diversification of influenza A/H1N1pdm. PLoS Curr 2009; 1:RRN1126.
31. Deyde VM, Okomo-Adhiambo M, Sheu TG, et al. Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses. Antiviral Res 2009; 81:16-24.
32. Deyde VM, Gubareva LV. Influenza genome analysis using pyrosequencing method: Current applications for a moving target. Expert Rev Mol Diagn 2009; 9:493-509.
33. Bloom JD, Gong LI, Baltimore D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 2010; 328:1272-5.
34. Holmes EC, Ghedin E, Miller N, et al. Whole-genome analysis of human influenza A virus reveals multiple persistent lineages reassortment among recent H3N2 viruses. PLoS Biol 2005; 3:e300.
35. Boivin G, Goyette N, Bernatchez H. Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient. Clin Infect Dis 2002; 34:E23-5.
36. Garten RJ, Davis CT, Russell CA, et al. Antigenic genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197-201.
37. Hurt AC, Holien JK, Barr IG. In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses. Antimicrob Agents Chemother 2009; 53:4433-40.